270 related articles for article (PubMed ID: 23484796)
1. Dabigatran and postmarketing reports of bleeding.
Southworth MR; Reichman ME; Unger EF
N Engl J Med; 2013 Apr; 368(14):1272-4. PubMed ID: 23484796
[No Abstract] [Full Text] [Related]
2. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
Sipahi I; Celik S; Tozun N
JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
[No Abstract] [Full Text] [Related]
3. Dabigatran, bleeding, and the regulators.
Moore TJ; Cohen MR; Mattison DR
BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
[No Abstract] [Full Text] [Related]
4. Is there really misuse and abuse of dabigatran?
Eikelboom JW; Hankey GJ
Med J Aust; 2013 Apr; 198(7):358-9. PubMed ID: 23581946
[No Abstract] [Full Text] [Related]
5. The trouble with dabigatran.
Charlton B; Redberg R
BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
[No Abstract] [Full Text] [Related]
6. Multiple data sources, the best way to gather safety information about medications.
Katz MH
JAMA Intern Med; 2014 Jan; 174(1):151. PubMed ID: 24248326
[No Abstract] [Full Text] [Related]
7. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
Vaughan Sarrazin MS; Jones M; Mazur A; Chrischilles E; Cram P
Am J Med; 2014 Dec; 127(12):1179-85. PubMed ID: 25107386
[TBL] [Abstract][Full Text] [Related]
8. The importance of postapproval data for dabigatran.
Redberg RF
JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
[No Abstract] [Full Text] [Related]
9. Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
McConeghy KW; Bress A; Qato DM; Wing C; Nutescu EA
Pharmacotherapy; 2014 Jun; 34(6):561-9. PubMed ID: 24644100
[TBL] [Abstract][Full Text] [Related]
10. Risk of bleeding with dabigatran in atrial fibrillation.
Hernandez I; Baik SH; Piñera A; Zhang Y
JAMA Intern Med; 2015 Jan; 175(1):18-24. PubMed ID: 25365537
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
12. Bleeding risk with dabigatran in the frail elderly.
Harper P; Young L; Merriman E
N Engl J Med; 2012 Mar; 366(9):864-6. PubMed ID: 22375994
[No Abstract] [Full Text] [Related]
13. [Dabigatran and risk of bleeding].
Hasler S
Praxis (Bern 1994); 2015 Jan; 104(3):157-8. PubMed ID: 25626386
[No Abstract] [Full Text] [Related]
14. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data.
Hernandez I; Zhang Y
JAMA Intern Med; 2015 Jul; 175(7):1245-7. PubMed ID: 26146922
[No Abstract] [Full Text] [Related]
15. Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.
Carney EF
Nat Rev Nephrol; 2015 Jan; 11(1):3. PubMed ID: 25421829
[No Abstract] [Full Text] [Related]
16. [New anticoagulants, new emergencies?].
Djalali S
Praxis (Bern 1994); 2013 Jul; 102(15):945-6. PubMed ID: 23876694
[No Abstract] [Full Text] [Related]
17. Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.
Rockey DC
Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):131-2. PubMed ID: 25601661
[TBL] [Abstract][Full Text] [Related]
18. Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
Henriksen DP; Hansen MR; Damkier P
JAMA Intern Med; 2015 Jul; 175(7):1245. PubMed ID: 26146921
[No Abstract] [Full Text] [Related]
19. Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
Liu S; Kim CO; Lucyk SN
JAMA Intern Med; 2015 Jul; 175(7):1244-5. PubMed ID: 26146920
[No Abstract] [Full Text] [Related]
20. The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation.
Klil-Drori A; Azoulay L
JAMA Intern Med; 2015 Jul; 175(7):1243-4. PubMed ID: 26146918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
